New Evidence on SAPIEN 3 Ultra RESILIA Valve Set to Boost EW Stock [Yahoo! Finance]
Globus Medical, Inc. Class A (GMED)
Last globus medical, inc. class a earnings: 2/20 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.globusmedical.com
Company Research
Source: Yahoo! Finance
extensive body of evidence on the company's SAPIEN valve platform, backed by multiple years of follow-up and more than 10 years of clinical experience with the RESILIA tissue. The latest development is expected to boost the market sentiment toward EW stock, as Edwards is focused on positioning TAVR for long-term growth and the announcement provides further evidence of the effectiveness of its SAPIEN 3 Ultra RESILIA valve. The study found that patients who received the SAPIEN 3 Ultra RESILIA valve experienced outstanding one-year outcomes, including extremely low mortality, low rates of reintervention, larger effective orifice areas, lower echo-derived gradients across all valve sizes, and no paravalvular leak in 84.4% of cases. The global TAVR market is expected to grow at a compound annual rate of 7.2% by 2030, driven by the rising prevalence of aortic valve stenosis, increasing preference for minimally invasive procedures, and the expanding geriatric population. In the past
Show less
Read more
Impact Snapshot
Event Time:
GMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMED alerts
High impacting Globus Medical, Inc. Class A news events
Weekly update
A roundup of the hottest topics
GMED
News
- Reasons to Add GMED Stock to Your Portfolio Right Now [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Truist Financial Co. from $85.00 to $90.00. They now have a "hold" rating on the stock.MarketBeat
- Confocal Microscope Market is Projected to Reach $1.8 Billion with 3.3% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]Yahoo! Finance
- Reasons to Retain STE Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.MarketBeat
GMED
Earnings
- 11/5/24 - Beat
GMED
Sec Filings
- 12/4/24 - Form 4
- 12/2/24 - Form 144
- 11/25/24 - Form 4
- GMED's page on the SEC website